NEW YORK, Oct. 14 (GenomeWeb News) - Epoch Biosciences said today that it has reached an agreement with Millennium Pharmaceuticals for its MGB Eclipse Probe Systems for multiplexed gene expression analysis.

Epoch said it would develop, functionally test, and supply multiplexed MGB Eclipse assays to gene targets specified by Millennium.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.